October 19, 2017 7:36 PM ET

Hotels, Restaurants and Leisure

Company Overview of Hoverink Biotechnologies, Inc.

Company Overview

Hoverink Biotechnologies, Inc. focuses on the development of recreational amusement parks. It intends to develop and operate Hoverink recreational centers in the United States. The company was formerly known as Hoverink International Holdings, Inc. and changed its name to Hoverink Biotechnologies, Inc. in September 2017. Hoverink Biotechnologies, Inc. was founded in 2013 and is based in Los Angeles, California.

1801 Century Park E.

24th Floor

Los Angeles, CA 90067

United States

Founded in 2013

3 Employees

Phone:

866-443-4666

Key Executives for Hoverink Biotechnologies, Inc.

CEO, Principal Financial Officer, Principal Accounting Officer, Treasurer & Director
Age: 52
Chairman of the Board of Directors and President
Age: 42
VP & Director
Age: 36
Compensation as of Fiscal Year 2017.

Hoverink Biotechnologies, Inc. Key Developments

Hoverink Biotechnologies, Inc. Files Form 15

Hoverink Biotechnologies, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common stock under the Securities Exchange Act of 1934, as amended. The par value of the company's common stock was $0.0001 per share.

SEC Orders Hearings On Registration Suspension Or Revocation Against Hoverink International Holdings, Inc. For Failure To Make Required Periodic Filings

Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of Hoverink International Holdings, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.

Hoverink International Holdings Inc. has Changed its Name to Hoverink Biotechnologies Inc

On September 11, 2017, Hoverink International Holdings Inc. changed its name to Hoverink Biotechnologies Inc.

Similar Private Companies By Industry

Company Name Region
1 Hotel South Beach, Inc. United States
1000 Acres Ranch Resort, Inc. United States
1001 Marquette LLC United States
11 East 1st St. LLC United States
11 Howard Hotel United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 3, 2017
--
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Hoverink Biotechnologies, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.